About | Free Trial

Last Update

2016-02-12T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Harley Tse?

Dr. Harley Tse Y.

[Object Object]

[object Object]

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

[object Object]

Background Information

Employment History

Professor of Immunology

Wayne State University

Affiliations

Research Fellow
Merck Sharp and Dohme Research Laboratories

Education

Ph.D.

Web References (25 Total References)


The vaccine could also target strokes ...

ohcampus.com [cached]

The vaccine could also target strokes which are a product of plaque buildup in arteries," said Harley Tse, a professor of immunology and microbiology in Wayne State University's school of medicine.

...
Shaw and Tse demonstrated that two T cell epitopes of the autoantigen "apoB100 are deeply involved in the development of the disease.
Although T-cells of the immune system are known to participate in the development of heart disease, by what and how these T-cells are directed to act has not been elucidated.
"With the discovery of the disease-causing T-cell epitopes, we can now manipulate the activities of the T-cells responding to these epitopes to control the disease," Shaw said.
Shaw and Tse conceptualised that finding the "apoB100 epitopes capable of stimulating the disease causing (atherogenic) T-cells is a prerequisite to understand how these T-cells are involved in heart disease development and how to control their adverse effects.
They identified two short sequences of "apoB100 that were able to direct specific T-cells to proliferate as well as to cause worsening atherosclerosis.
"This discovery is significant because it identifies the target T-cells and makes it possible to manipulate this population of pathologic T-cells away from their harmful activities," Shaw and Tse said.


The vaccine could also target strokes ...

www.dailypioneer.com [cached]

The vaccine could also target strokes which are a product of plaque buildup in arteries," said Harley Tse, a professor of immunology and microbiology in Wayne State University's school of medicine.

...
Shaw and Tse demonstrated that two T cell epitopes of the autoantigen "apoB100" are deeply involved in the development of the disease. Although T-cells of the immune system are known to participate in the development of heart disease, by what and how these T-cells are directed to act has not been elucidated. "With the discovery of the disease-causing T-cell epitopes, we can now manipulate the activities of the T-cells responding to these epitopes to control the disease," Shaw said. Shaw and Tse conceptualised that finding the "apoB100" epitopes capable of stimulating the disease causing (atherogenic) T-cells is a prerequisite to understand how these T-cells are involved in heart disease development and how to control their adverse effects. They identified two short sequences of "apoB100" that were able to direct specific T-cells to proliferate as well as to cause worsening atherosclerosis. "This discovery is significant because it identifies the target T-cells and makes it possible to manipulate this population of pathologic T-cells away from their harmful activities," Shaw and Tse said. The novel discovery is reported in the Journal of Immunology and Clinical Research.


The vaccine could also target strokes ...

www.deccanherald.com [cached]

The vaccine could also target strokes which are a product of plaque buildup in arteries," said Harley Tse, a professor of immunology and microbiology in Wayne State University's school of medicine.

...
Shaw and Tse demonstrated that two T cell epitopes of the autoantigen "apoB100" are deeply involved in the development of the disease.
Although T-cells of the immune system are known to participate in the development of heart disease, by what and how these T-cells are directed to act has not been elucidated.
"With the discovery of the disease-causing T-cell epitopes, we can now manipulate the activities of the T-cells responding to these epitopes to control the disease," Shaw said.
Shaw and Tse conceptualised that finding the "apoB100" epitopes capable of stimulating the disease causing (atherogenic) T-cells is a prerequisite to understand how these T-cells are involved in heart disease development and how to control their adverse effects.
They identified two short sequences of "apoB100" that were able to direct specific T-cells to proliferate as well as to cause worsening atherosclerosis.
"This discovery is significant because it identifies the target T-cells and makes it possible to manipulate this population of pathologic T-cells away from their harmful activities," Shaw and Tse said.


The published work, performed in the ...

www.eurekalert.org [cached]

The published work, performed in the laboratory of Klaus Ley, M.D., a prominent vascular biologist of LIAI, was based on the fundamental discovery made by Harley Tse, Ph.D., professor of immunology and microbiology in Wayne State's School of Medicine, and professor in Wayne State's Cardiovascular Research Institute, and Michael Shaw, Ph.D., adjunct assistant professor of immunology and microbiology at Wayne State.

...
Shaw and Tse are the first to demonstrate that two T cell epitopes of the autoantigen apoB100 are deeply involved in the development of the disease.
...
"ApoB100 is an apolipoprotein of the LDL (low-density lipoprotein) particle which is the notorious 'bad cholesterol' that contributes to the formation of plaques in the vessel wall," said Tse. "Although T cells of the immune system are known to participate in the development of heart disease, by what and how these T cells are directed to act have not been elucidated. The lack of this knowledge has greatly hampered the development of immune peptide-based therapeutics to control the disease. With the discovery of the disease-causing T cell epitopes, we can now manipulate the activities of the T cells responding to these epitopes to control the disease."
Since immune T cells are normally activated by a short sequence (called an epitope), and not by the whole molecule of an antigen, Shaw and Tse conceptualized that finding the apoB100 epitopes capable of stimulating the disease causing (atherogenic) T cells is a prerequisite for understanding how these T cells are involved in heart disease development and for finding ways to control their adverse effects.
...
Substantial funding for Dr. Tse's research was provided by the Office of the Vice President for Research at Wayne State University.


Ley collaborated with fellow La Jolla ...

www.news-line.com [cached]

Ley collaborated with fellow La Jolla Institute scientist Alessandro Sette, PhD and Dr. Tse of Wayne State University in Michigan, to identify the specific peptides, which prompt the arterial attack in mice - the byproduct of which is inflammation.

Similar Profiles

Other People with this Name

Other people with the name Tse

Decky Tse
Grand Power Express International Limited

Fionna Tse
BFL Canada Inc

Jason Tse
M&G Investments Pte Ltd

Hennis Tse
ChildPsy

Grace Tse
ChildPsy

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory